Xiaflex Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.


Oxaliplatin Injection, USP, used in combination with infusional 5-fluorouracil/leucovorin, is indicated for:
• adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor.
• treatment of advanced colorectal cancer.


There is currently no drug history available for this drug.

Other Information

Oxaliplatin Injection, USP is an antineoplastic agent with the molecular formula C8H14N2O4Pt and the chemical name is cis-[(1 R,2 R)-1,2-cyclohexanediamine-N,N’] [oxalato(2-)-O,O’] platinum. Oxaliplatin is an organoplatinum complex in which the platinum atom is complexed with 1,2-diaminocyclohexane(DACH) and with an oxalate ligand as a leaving group.


The molecular weight is 397.3. Oxaliplatin is slightly soluble in water at 6 mg/mL, very slightly soluble in methanol, and practically insoluble in ethanol and acetone.

Oxaliplatin Injection, USP is supplied in vials containing 50 mg or 100 mg of oxaliplatin as a sterile, preservative-free, aqueous solution at a concentration of 5 mg/mL. Water for injection is present as inactive ingredient.

Xiaflex Manufacturers

  • Auxilium Pharmaceuticals, Inc.
    Xiaflex (Collagenase Clostridium Histolyticum) Kit [Auxilium Pharmaceuticals, Inc.]

Login To Your Free Account